Lazard Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,104
| Closed | -$275K | – | 2290 |
|
|
2025
Q1 | $275K | Buy |
26,104
+19,414
| +290% | +$205K | ﹤0.01% | 1556 |
|
|
2024
Q4 | $112K | Sell |
6,690
-2,299
| -26% | -$38.5K | ﹤0.01% | 1767 |
|
|
2024
Q3 | $207K | Buy |
8,989
+39
| +0.4% | +$898 | ﹤0.01% | 1598 |
|
|
2024
Q2 | $216K | Sell |
8,950
-10,489
| -54% | -$253K | ﹤0.01% | 1530 |
|
|
2024
Q1 | $655K | Sell |
19,439
-8,439
| -30% | -$284K | ﹤0.01% | 1004 |
|
|
2023
Q4 | $877K | Buy |
27,878
+18,161
| +187% | +$571K | ﹤0.01% | 977 |
|
|
2023
Q3 | $247K | Sell |
9,717
-2,217
| -19% | -$56.4K | ﹤0.01% | 1311 |
|
|
2023
Q2 | $341K | Buy |
11,934
+2,632
| +28% | +$75.2K | ﹤0.01% | 1204 |
|
|
2023
Q1 | $222K | Buy |
9,302
+987
| +12% | +$23.6K | ﹤0.01% | 1280 |
|
|
2022
Q4 | $140K | Sell |
8,315
-666
| -7% | -$11.2K | ﹤0.01% | 1392 |
|
|
2022
Q3 | $133K | Buy |
+8,981
| New | +$133K | ﹤0.01% | 1364 |
|